Clinical Trial: TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Lymphoblastic Leukemia
Study Type: INTERVENTIONAL
Official Title: TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Brief Summary:
The purpose of this study is to improve upon the TINI study treatment.The study will test the ability of a type of immunotherapy called blinatumomab to clear persistent leukemia.Blinatumomab targets CD19 which is located on the leukemia cells outer membrane.
Read more